BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29893471)

  • 21. Childhood and Adolescent nodular lymphocyte predominant Hodgkin lymphoma - A review of clinical outcome based on the histological variants.
    Shankar AG; Kirkwood AA; Hall GW; Hayward J; O'Hare P; Ramsay AD
    Br J Haematol; 2015 Oct; 171(2):254-262. PubMed ID: 26115355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group.
    Biasoli I; Stamatoullas A; Meignin V; Delmer A; Reman O; Morschhauser F; Coiffier B; Bosly A; Diviné M; Brice P
    Cancer; 2010 Feb; 116(3):631-9. PubMed ID: 20029973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis.
    Xing KH; Connors JM; Lai A; Al-Mansour M; Sehn LH; Villa D; Klasa R; Shenkier T; Gascoyne RD; Skinnider B; Savage KJ
    Blood; 2014 Jun; 123(23):3567-73. PubMed ID: 24713929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variant histology of pediatric nodular lymphocyte-predominant Hodgkin lymphoma with IgD and CD30 expression.
    Ali N; Moussa E; Khorshed E; Zaghloul MS; Elnashar A; Abdalla A
    Pediatr Blood Cancer; 2023 Nov; 70(11):e30647. PubMed ID: 37638819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group.
    Eichenauer DA; Plütschow A; Fuchs M; von Tresckow B; Böll B; Behringer K; Diehl V; Eich HT; Borchmann P; Engert A
    J Clin Oncol; 2015 Sep; 33(26):2857-62. PubMed ID: 26240235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).
    Hartmann S; Eichenauer DA; Plütschow A; Mottok A; Bob R; Koch K; Bernd HW; Cogliatti S; Hummel M; Feller AC; Ott G; Möller P; Rosenwald A; Stein H; Hansmann ML; Engert A; Klapper W
    Blood; 2013 Dec; 122(26):4246-52; quiz 4292. PubMed ID: 24100447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nodular lymphocyte predominant Hodgkin's lymphoma.
    Siddiqui N; Al-Diab AI
    Saudi Med J; 2005 Feb; 26(2):241-5. PubMed ID: 15770298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcomes in patients with early stage nodular lymphocyte-predominant Hodgkin's lymphoma treated with radiotherapy.
    Solanki AA; LeMieux MH; Chiu BC; Mahmood U; Hasan Y; Koshy M
    PLoS One; 2013; 8(9):e75336. PubMed ID: 24058675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?
    Barber NA; Loberiza FR; Perry AM; Bast M; Holdeman KP; Esfahane AB; Weisenburger DD; Vose J; Bierman P; Armitage JO; Bociek RG
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):392-7. PubMed ID: 23773450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Follow-Up of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group.
    Eichenauer DA; Plütschow A; Fuchs M; Sasse S; Baues C; Böll B; von Tresckow B; Diehl V; Borchmann P; Engert A
    J Clin Oncol; 2020 Mar; 38(7):698-705. PubMed ID: 31626571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variant histology in nodular lymphocyte predominant Hodgkin lymphoma in an adult population: disease investigations and characteristics from a retrospective cohort.
    Stacey A; Marks AJ; Naresh KN
    J Clin Pathol; 2023 Feb; 76(2):137-140. PubMed ID: 35483890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party.
    Akhtar S; Montoto S; Boumendil A; Finel H; Masszi T; Jindra P; Nemet D; Fuhrmann S; Beguin Y; Castagna L; Ferrara F; Capria S; Malladi R; Moraleda JM; Bloor A; Ghesquières H; Meissner J; Sureda A; Dreger P
    Am J Hematol; 2018 Jan; 93(1):40-46. PubMed ID: 28971503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The stage-specific roles of radiotherapy and chemotherapy in nodular lymphocyte predominant Hodgkin lymphoma patients: a propensity score-matched analysis of the SEER database.
    Wang S; Jia M; Han J; Zhang R; Huang K; Qiao Y; Chen P; Fu Z
    Cancer Med; 2021 Jan; 10(2):540-551. PubMed ID: 33249743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relapsed or poorly responsive nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents - a report from the United Kingdom's Children's Cancer and Leukaemia Study Group.
    Shankar AG; Kirkwood AA; Depani S; Bianchi E; Hayward J; Ramsay AD; Hall GW
    Br J Haematol; 2016 May; 173(3):421-31. PubMed ID: 26996288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma.
    Advani RH; Horning SJ; Hoppe RT; Daadi S; Allen J; Natkunam Y; Bartlett NL
    J Clin Oncol; 2014 Mar; 32(9):912-8. PubMed ID: 24516013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nodular lymphocyte predominant Hodgkin lymphoma: Experience of Polish Pediatric Leukemia/Lymphoma Study Group.
    Klekawka T; Balwierz W; Brozyna A; Chaber R; Dadela-Urbanek A; Koltan A; Kwasnicka J; Mitura-Lesiuk M; Muszynska-Roslan K; Przybyszewski B; Ruranska I; Smalisz K; Mizia-Malarz A; Stachowicz-Stencel T; Stolarska M; Wziatek A; Zielezinska K; Skoczen S
    Pediatr Hematol Oncol; 2021 Oct; 38(7):609-619. PubMed ID: 33734010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.
    Fan Z; Natkunam Y; Bair E; Tibshirani R; Warnke RA
    Am J Surg Pathol; 2003 Oct; 27(10):1346-56. PubMed ID: 14508396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nodular lymphocyte-predominant Hodgkin lymphoma.
    Fuchs M; Eichenauer DA; Nogová L; Diehl V; Engert A;
    Curr Hematol Malig Rep; 2008 Jul; 3(3):126-31. PubMed ID: 20425457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary Extranodal Nodular Lymphocyte Predominant Hodgkin Lymphoma Involving the Thyroid.
    Williams TP; Raess PW; Braziel R; Cascio MJ
    Head Neck Pathol; 2020 Jun; 14(2):550-553. PubMed ID: 31292857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nodular lymphocyte predominant Hodgkin lymphoma.
    Lee AI; LaCasce AS
    Oncologist; 2009 Jul; 14(7):739-51. PubMed ID: 19605845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.